Landmark deal for UQ-Trinity inflammation startup

Landmark deal for UQ-Trinity inflammation startup

28 Sep 20 admin Discovery 0 Comments

The Inflammasome Lab is thrilled to have contributed to the development NLRP3 inhibitors, now under translation to the clinic by Roche for treatment of inflammatory and neurodegenerative diseases. Read announcement here.

Posted by admin

ABOUT Inflammasome Lab

Inflammasome Lab is a group of researchers led by Prof Kate Schroder at the Institute for Molecular Bioscience, The University of Queensland.
We seek to unravel the secrets of inflammasomes – protein complexes at the heart of inflammation and disease – to allow for new therapies to fight human diseases.